載入...
Isorhamnetin Protects against Doxorubicin-Induced Cardiotoxicity In Vivo and In Vitro
Doxorubicin (Dox) is an anthracycline antibiotic for cancer therapy with limited usage due to cardiotoxicity. Isorhamnetin is a nature antioxidant with obvious cardiac protective effect. The aim of this study is going to investigate the possible protective effect of isorhamnetin against Dox-induced...
Na minha lista:
Main Authors: | , , , , , , , , , , |
---|---|
格式: | Artigo |
語言: | Inglês |
出版: |
Public Library of Science
2013
|
主題: | |
在線閱讀: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3665796/ https://ncbi.nlm.nih.gov/pubmed/23724057 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0064526 |
標簽: |
添加標簽
沒有標簽, 成為第一個標記此記錄!
|